Last reviewed · How we verify
Human Papillomavirus vaccine
Human Papillomavirus vaccine is a Biologic drug developed by Dalhousie University. It is currently FDA-approved. Also known as: qHPV vaccine, Gardasil, HPV vaccine, Gardasil.
The Human Papillomavirus vaccine, developed by Dalhousie University, is currently marketed but lacks detailed revenue figures and primary trial results. A key strength is the protection of its core composition patent, which expires in 2028, providing a period of exclusivity. The primary risk is the lack of specified competitors and detailed clinical data, which may impact market positioning and adoption.
At a glance
| Generic name | Human Papillomavirus vaccine |
|---|---|
| Also known as | qHPV vaccine, Gardasil, HPV vaccine, Gardasil |
| Sponsor | Dalhousie University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer (PHASE2)
- Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination (PHASE2)
- A Randomized Trial of Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers (NA)
- Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants (PHASE2)
- Testing RG1-VLP Vaccine to Prevent HPV-related Cancers (PHASE1)
- Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PHASE4)
- Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines (PHASE4)
- TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Human Papillomavirus vaccine CI brief — competitive landscape report
- Human Papillomavirus vaccine updates RSS · CI watch RSS
- Dalhousie University portfolio CI
Frequently asked questions about Human Papillomavirus vaccine
What is Human Papillomavirus vaccine?
Who makes Human Papillomavirus vaccine?
Is Human Papillomavirus vaccine also known as anything else?
What development phase is Human Papillomavirus vaccine in?
Related
- Manufacturer: Dalhousie University — full pipeline
- Also known as: qHPV vaccine, Gardasil, HPV vaccine, Gardasil
- Compare: Human Papillomavirus vaccine vs similar drugs
- Pricing: Human Papillomavirus vaccine cost, discount & access